IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jake burns who wrote (924)	7/12/1998 10:08:00 PM
From: Manny Gugliuzza	of 1510

most definitely we are still immune based therapy. i did not want to leave anything out and anything that is used for treatment or will even be available for therapy can negatively impact the stock. people once they start medication, if they do well with no side effects ,unless their doctors change their meds, will not be looking for something different unless IMNR can have great media coverage which will hopefully improve as time goes on. then they can request a change. but still public perception for investment is product available, sales and earnings rise. thus it draws away from us. ar.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next